In development: Guidance, quality standards and advice
Showing 1 to 1 of 1
| Title | Type | Expected publication date |
|---|---|---|
| Niraparib with dostarlimab for maintenance treatment of advanced or recurrent endometrial cancer [ID6316] | Technology appraisal guidance | TBC |